Biopharma

Will Durham’s Emergo Therapeutics be fourth big startup hit for Moise Khayrallah?

DURHAM – Moise Khayrallah, Ph.D., is a serial entrepreneur with a Midas touch. Three biopharmaceutical start-ups he co-founded in recent years were quickly sold to larger companies for more than $400…